Dr Drews Adade reveals how bias in medical research leads to missed diagnoses, unequal treatment, and preventable deaths ...

With Bluetooth glucometers, each test can spark insight — syncing data into apps, revealing patterns, and helping doctors and patients act sooner.

Type 2 diabetes remission may be achievable through a culturally tailored app-based program offering diet, exercise, and ...

Glucagon-like peptide 1 receptor agonists (GLP-1RA) have made waves as treatments for obesity and type 2 diabetes, but a new report suggests they might also have clinical benefits for certain patients ...

Remote patient monitoring that relies only on text messages could help drive engagement, compliance and outcomes at scale.

Background Data on cardiorespiratory fitness (CRF) in psoriatic arthritis (PsA) are scarce. This study aimed to determine the ...

Oats: The Heart Health Champion Whole grains are rich in fiber, antioxidants, and essential vitamins and minerals that ...

The use of GLP-1RAs may improve RA disease activity and cardiovascular risk profiles among patients with overweight or obesity.

Eli Lilly finds itself navigating turbulent market conditions following unexpected political developments from the White House. Former President Donald Trump's recent announcement regarding ...

Sanofi's Tzield accepted for expedited review in the US for stage 3 type 1 diabetes through FDA Commissioner's National Priority Voucher pilot program If approved, Tzield would be the first disease-mo ...